HK1030937A1 - New substituted dimeric compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

New substituted dimeric compounds, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
HK1030937A1
HK1030937A1 HK01101746A HK01101746A HK1030937A1 HK 1030937 A1 HK1030937 A1 HK 1030937A1 HK 01101746 A HK01101746 A HK 01101746A HK 01101746 A HK01101746 A HK 01101746A HK 1030937 A1 HK1030937 A1 HK 1030937A1
Authority
HK
Hong Kong
Prior art keywords
nr1c
nr2r3
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
HK01101746A
Other languages
English (en)
Inventor
Patrick Depreux
Said Yous
Gwenael Cheve
Gerald Guillaumet
Marie-Claude Viaud
Carlos Larraya
Caroline Bennejean
Philippe Delagrange
Pierre Renard
Carole Descamps-Francois
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1030937A1 publication Critical patent/HK1030937A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
HK01101746A 1999-05-19 2001-03-12 New substituted dimeric compounds, a process for their preparation and pharmaceutical compositions containing them HK1030937A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9906331A FR2793793B1 (fr) 1999-05-19 1999-05-19 Nouveaux derives dimeriques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
HK1030937A1 true HK1030937A1 (en) 2001-05-25

Family

ID=9545746

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01101746A HK1030937A1 (en) 1999-05-19 2001-03-12 New substituted dimeric compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US6310074B1 (hu)
EP (1) EP1057826B1 (hu)
JP (1) JP3688552B2 (hu)
KR (1) KR100472520B1 (hu)
CN (1) CN1128142C (hu)
AT (1) ATE237610T1 (hu)
AU (1) AU766322B2 (hu)
BR (1) BR0003313A (hu)
DE (1) DE60002126T2 (hu)
DK (1) DK1057826T3 (hu)
EA (1) EA003391B1 (hu)
ES (1) ES2197062T3 (hu)
FR (1) FR2793793B1 (hu)
HK (1) HK1030937A1 (hu)
HU (1) HUP0001961A3 (hu)
NO (1) NO20002548L (hu)
NZ (1) NZ504613A (hu)
PL (1) PL340165A1 (hu)
PT (1) PT1057826E (hu)
SI (1) SI1057826T1 (hu)
ZA (1) ZA200002490B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1713908B (zh) * 2002-12-03 2010-05-12 弗·哈夫曼-拉罗切有限公司 作为5-ht6-受体配体用于治疗中枢神经系统病症的氨基烷氧基吲哚
DK1696920T3 (en) 2003-12-19 2015-01-19 Plexxikon Inc RELATIONS AND PROCEDURES FOR THE DEVELOPMENT OF LAW MODULATORS
US7498342B2 (en) * 2004-06-17 2009-03-03 Plexxikon, Inc. Compounds modulating c-kit activity
JP2008545652A (ja) * 2005-05-17 2008-12-18 プレキシコン，インコーポレーテッド ｃ−ｋｉｔおよびｃ−ｆｍｓ活性を調節する化合物およびその用途
MY153898A (en) * 2005-06-22 2015-04-15 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
PE20081581A1 (es) * 2006-12-21 2008-11-12 Plexxikon Inc COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
WO2008079909A1 (en) * 2006-12-21 2008-07-03 Plexxikon, Inc. Pyrrolo [2,3-b] pyridines as kinase modulators
RU2009122670A (ru) 2006-12-21 2011-01-27 Плекссикон, Инк. (Us) Соединения и способы для модуляции киназ и показания к их применению
MX2010000617A (es) 2007-07-17 2010-05-17 Plexxikon Inc Compuestos y metodos para modulacion de cinasa, e indicaciones de estos.
CN102112480A (zh) * 2008-07-30 2011-06-29 菲尔若国际公司 1,6-二氢-2h-3-氧杂-6-氮杂-不对称引达省化合物
NZ594398A (en) 2009-04-03 2014-03-28 Plexxikon Inc Propane-1-sulfonic acid (3-[5-(4-chloro-phenyl)-1h-pyrrol [2, 3-b] pyridine-3-carbonyl]-2,4-difluoro-phenyl} -amide compositions and uses thereof
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
KR20120102669A (ko) 2009-11-06 2012-09-18 플렉시콘, 인코퍼레이티드 키나제 조정을 위한 화합물 및 방법, 및 이를 위한 적응증
US9624213B2 (en) 2011-02-07 2017-04-18 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
TWI558702B (zh) 2011-02-21 2016-11-21 普雷辛肯公司 醫藥活性物質的固態形式
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1639427A3 (ru) * 1987-07-03 1991-03-30 Глэксо Груп Лимитед (Фирма) Способ получени производных индола или их фармацевтически приемлемых солей
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE138374T1 (de) * 1991-11-18 1996-06-15 Lilly Industries Ltd Benzo(b)thiophen-2-carboxamide zur behandlung von krankheiten des zentralnervensystems
FR2689124A1 (fr) * 1992-03-27 1993-10-01 Adir Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2696453B1 (fr) * 1992-10-02 1994-12-23 Adir Nouveaux arylalkyl(thio)amides, leur procédé de préparation, et les compositions pharmaceutiques qui les contiennent.
WO1994014769A1 (en) * 1992-12-21 1994-07-07 Taisho Pharmaceutical Co., Ltd. N-substituted indole derivative
PT767782E (pt) * 1994-06-29 2002-03-28 Pfizer Derivados arilo e heteroarilo de alcoxinaftalenos
FR2731223A1 (fr) * 1995-03-02 1996-09-06 Pf Medicament Nouveaux derives bi-tryptaminiques, leur procede de preparation et leur utilisation a titre de medicaments

Also Published As

Publication number Publication date
EP1057826A1 (fr) 2000-12-06
NZ504613A (en) 2001-06-29
US6310074B1 (en) 2001-10-30
DE60002126T2 (de) 2004-03-18
BR0003313A (pt) 2001-03-13
PT1057826E (pt) 2003-08-29
CN1128142C (zh) 2003-11-19
EA200000431A3 (ru) 2001-02-26
KR20010029729A (ko) 2001-04-16
HU0001961D0 (en) 2000-07-28
JP2001011035A (ja) 2001-01-16
HUP0001961A3 (en) 2002-10-28
PL340165A1 (en) 2000-11-20
NO20002548L (no) 2000-11-20
CN1277962A (zh) 2000-12-27
DK1057826T3 (da) 2003-07-21
ES2197062T3 (es) 2004-01-01
SI1057826T1 (en) 2003-08-31
FR2793793A1 (fr) 2000-11-24
HUP0001961A2 (hu) 2001-08-28
EA200000431A2 (ru) 2000-12-25
FR2793793B1 (fr) 2004-02-27
DE60002126D1 (de) 2003-05-22
NO20002548D0 (no) 2000-05-18
ZA200002490B (en) 2000-11-20
AU766322B2 (en) 2003-10-16
EA003391B1 (ru) 2003-04-24
EP1057826B1 (fr) 2003-04-16
KR100472520B1 (ko) 2005-03-07
ATE237610T1 (de) 2003-05-15
JP3688552B2 (ja) 2005-08-31
AU3542000A (en) 2000-11-23

Similar Documents

Publication Publication Date Title
HK1030937A1 (en) New substituted dimeric compounds, a process for their preparation and pharmaceutical compositions containing them
CA2322644A1 (en) Pharmaceutical composition of topiramate
PL340836A1 (en) Novel compounds
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
IL112622A (en) Iminoalkylamino or aminoalkylideneamino camptothecin derivatives, process for their preparation and pharmaceutical compositions containing them
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
ATE45153T1 (de) Benzisoselenazolthione, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische produkte.
HUT54705A (en) Process for producing 11 beta-aryl-4-estrenes and pharmaceutical compositions comprising same
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
SG64906A1 (en) New bis-naphthalimides for the treatment of cancer
GEP20032914B (en) Derivatives of 1,3,4-Oxadiazolone
NZ222045A (en) From diamides up to tetrapeptides for use as anticanvulsants
CS368890A3 (en) Aminooligohydroxy derivatives inhibiting effects of renin, process for their preparation and a pharmaceutical containing them
EP1295874A3 (en) Retroviral protease inhibiting compounds
BG101163A (en) 8-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them
IL133222A0 (en) Pharmaceutical compositions containing cinchonine dichlorohydrate
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
BG101071A (en) Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same
IT8719351A0 (it) Composti ad attivita'epatoprotettrice e mucolitica, procedimento per la loro preparazione e composizioni farmaceutiche relative.
ATE32514T1 (de) 3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
MX9703610A (es) Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090519